These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26117767)

  • 1. Biomimetic synthesized chiral mesoporous silica: Structures and controlled release functions as drug carrier.
    Li J; Xu L; Yang B; Bao Z; Pan W; Li S
    Mater Sci Eng C Mater Biol Appl; 2015 Oct; 55():367-72. PubMed ID: 26117767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facile synthesis of functionalized ionic surfactant templated mesoporous silica for incorporation of poorly water-soluble drug.
    Li J; Xu L; Yang B; Wang H; Bao Z; Pan W; Li S
    Int J Pharm; 2015 Aug; 492(1-2):191-8. PubMed ID: 26163764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and preparation of mesoporous silica carriers with chiral structures for drug release differentiation.
    Wang Y; Li W; Liu T; Xu L; Guo Y; Ke J; Li S; Li H
    Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109737. PubMed ID: 31349514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesoporous silicas templated by heterocyclic amino acid derivatives: Biomimetic synthesis and drug release application.
    Li H; Ke J; Li H; Wei C; Wu X; Li J; Yang Y; Xu L; Liu H; Li S; Yang M; Wei M
    Mater Sci Eng C Mater Biol Appl; 2018 Dec; 93():407-418. PubMed ID: 30274073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enantioselectively controlled release of chiral drug (metoprolol) using chiral mesoporous silica materials.
    Guo Z; Du Y; Liu X; Ng SC; Chen Y; Yang Y
    Nanotechnology; 2010 Apr; 21(16):165103. PubMed ID: 20351409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of bare and amino modified mesoporous silica@poly(ethyleneimine)s xerogel as indomethacin carrier: Superiority of amino modification.
    Li J; Xu L; Wang H; Yang B; Liu H; Pan W; Li S
    Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():710-716. PubMed ID: 26652425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomimetic synthesis and evaluation of histidine-derivative templated chiral mesoporous silica for improved oral delivery of the poorly water-soluble drug, nimodipine.
    Li H; Li H; Wei C; Ke J; Li J; Xu L; Liu H; YangYang ; Li S; Yang M
    Eur J Pharm Sci; 2018 May; 117():321-330. PubMed ID: 29530545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug delivery formulations of ordered and nonordered mesoporous silica: comparison of three drug loading methods.
    Limnell T; Santos HA; Mäkilä E; Heikkilä T; Salonen J; Murzin DY; Kumar N; Laaksonen T; Peltonen L; Hirvonen J
    J Pharm Sci; 2011 Aug; 100(8):3294-3306. PubMed ID: 21520084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fabrication of mesoporous silica shells on solid silica spheres using anionic surfactants and their potential application in controlling drug release.
    El-Toni AM; Khan A; Ibrahim MA; Al-Hoshan M; Labis JP
    Molecules; 2012 Nov; 17(11):13199-210. PubMed ID: 23132137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enlarged Pore Size Chiral Mesoporous Silica Nanoparticles Loaded Poorly Water-Soluble Drug Perform Superior Delivery Effect.
    Guo Y; Gou K; Yang B; Wang Y; Pu X; Li S; Li H
    Molecules; 2019 Sep; 24(19):. PubMed ID: 31575047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploitation of 3D face-centered cubic mesoporous silica as a carrier for a poorly water soluble drug: influence of pore size on release rate.
    Zhu W; Wan L; Zhang C; Gao Y; Zheng X; Jiang T; Wang S
    Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():78-85. PubMed ID: 24268236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control-release microcapsule of famotidine loaded biomimetic synthesized mesoporous silica nanoparticles: Controlled release effect and enhanced stomach adhesion in vitro.
    Li J; Wang H; Yang B; Xu L; Zheng N; Chen H; Li S
    Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():273-7. PubMed ID: 26478311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Graft to" Synthesis and Ibuprofen-Loading Performance of pH-Sensitive PMAA-Silica Hybrid Nanoparticles with Controlled Bimodal Mesopores.
    Han J; Sun J; Bai S; Panezai H; Jin X; Wu X
    J Pharm Sci; 2015 Dec; 104(12):4299-4306. PubMed ID: 26501935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PLGA/mesoporous silica hybrid structure for controlled drug release.
    Xue JM; Shi M
    J Control Release; 2004 Aug; 98(2):209-17. PubMed ID: 15262413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chiral mesoporous silica synthesized by a facile strategy for loading and releasing poorly water-soluble drug.
    Gao Z; Lv X; Fu Y; Zang X; Sun Y; Li S; Zhang H; Qiao S; Wang L; Sun Y
    Drug Dev Ind Pharm; 2020 Jul; 46(7):1177-1184. PubMed ID: 32538184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The On-Off chiral mesoporous silica nanoparticles for delivering achiral drug in chiral environment.
    Fan N; Liu R; Ma P; Wang X; Li C; Li J
    Colloids Surf B Biointerfaces; 2019 Apr; 176():122-129. PubMed ID: 30597409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preparation and release behaviour of mesoporous silica/ethylcellulose sustained-release mini-matrix].
    Wu QL; Quan GL; Hong Y; Wu LN; Zeng YM; Li G; Pan X; Wu CB
    Yao Xue Xue Bao; 2015 Apr; 50(4):492-9. PubMed ID: 26223134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomimetic synthesized bimodal nanoporous silica: Bimodal mesostructure formation and application for ibuprofen delivery.
    Li J; Xu L; Zheng N; Wang H; Lu F; Li S
    Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():1105-11. PubMed ID: 26478410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface-functionalized diatom microcapsules for drug delivery of water-insoluble drugs.
    Aw MS; Bariana M; Yu Y; Addai-Mensah J; Losic D
    J Biomater Appl; 2013 Aug; 28(2):163-74. PubMed ID: 22457043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanostructure-loaded mesoporous silica for controlled release of coumarin derivatives: a novel testing of the hyperthermia effect.
    Al-Kady AS; Gaber M; Hussein MM; Ebeid el-ZM
    Eur J Pharm Biopharm; 2011 Jan; 77(1):66-74. PubMed ID: 20974253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.